Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jenny Gill

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The American Journal of Medicine|October 16, 2021
Multi-Cancer Screening Tests: Communicating About Risks Should be PrioritizedTimothée Olivier, Jenny Gill, Vinay Prasad
The American Journal of Medicine|May 27, 2022
Corrigendum to 'Multi-Cancer Screening Tests: Communicating About Risks Should be Prioritized' AmJMed 2021;135(4):413-415Timothée Olivier, Jenny Gill, Vinay Prasad
The American Journal of Medicine|February 16, 2023
The ReplyTimothée Olivier, Jenny Gill, Vinay Prasad
Cancer Medicine|March 22, 2022
Targeted therapy in lung cancer: Are we closing the gap in years of life lost?David J Benjamin, Alyson Haslam, Jenny Gill, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The American Journal of Medicine|October 16, 2021
Multi-Cancer Screening Tests: Communicating About Risks Should be PrioritizedTimothée Olivier, Jenny Gill, Vinay Prasad
The American Journal of Medicine|May 27, 2022
Corrigendum to 'Multi-Cancer Screening Tests: Communicating About Risks Should be Prioritized' AmJMed 2021;135(4):413-415Timothée Olivier, Jenny Gill, Vinay Prasad
The American Journal of Medicine|February 16, 2023
The ReplyTimothée Olivier, Jenny Gill, Vinay Prasad
Cancer Medicine|March 22, 2022
Targeted therapy in lung cancer: Are we closing the gap in years of life lost?David J Benjamin, Alyson Haslam, Jenny Gill, et al.
Pageof 1